---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-115911"
form_type: "8-K"
ticker: "APRE"
cik: "0001781983"
company_name: "Aprea Therapeutics, Inc."
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:55:19.141231+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Aprea Therapeutics enters ATM equity offering agreement for up to $3.0M with H.C. Wainwright

## Summary
- Aprea entered into an at-the-market offering agreement with H.C. Wainwright to sell up to $3.0M of common stock.
- HCW will serve as sales agent and receive a 3.0% commission on gross proceeds from sales.
- Net proceeds will fund general corporate purposes, including preclinical studies and clinical trials.
- The company is not obligated to sell any shares under the agreement; sales may occur from time to time.

## SEC filing metadata
- accession: 0001104659-24-115911
- form_type: 8-K
- ticker: APRE
- cik: 0001781983
- company_name: Aprea Therapeutics, Inc.
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1781983/000110465924115911/0001104659-24-115911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1781983/000110465924115911/tm2427608d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-115911
- JSON: https://secwatch.observer/filing/0001104659-24-115911.json
- Plain text: https://secwatch.observer/filing/0001104659-24-115911.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.